Dermatomyositis-like syndrome in x-linked agammaglobulinemia

Primary immunodeficiencies (PIDs) encompass more than 250 different pathological conditions. X-linked agammaglobulinemia (XLA) has been occasionally associated with cutaneous and muscular manifestations resembling dermatomyositis, often termed dermatomyositis-like syndrome (DLS). This syndrome has b...

Full description

Bibliographic Details
Main Authors: Pedro David Carvalho, Carlos Costa, Marília Rodrigues, Maria João Salvador, José António Pereira da Silva, Armando Malcata
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2016-01-01
Series:Acta Reumatológica Portuguesa
Subjects:
Online Access:http://www.actareumatologica.com/files/article/1091_dermatomyositis_like_syndrome_in_x_linked_agammaglobulinemia_file.pdf
id doaj-4a7fd89816f34ff391952e443c0f7049
record_format Article
spelling doaj-4a7fd89816f34ff391952e443c0f70492020-11-24T22:36:08ZengSociedade Portuguesa de ReumatologiaActa Reumatológica Portuguesa0303-464X2016-01-01201617881CC140325Dermatomyositis-like syndrome in x-linked agammaglobulinemiaPedro David Carvalho0Carlos Costa1Marília Rodrigues2Maria João Salvador3José António Pereira da Silva4Armando Malcata5Centro Hospitalar e Universitário de CoimbraCentro Hospitalar e Universitário de CoimbraCentro Hospitalar e Universitário de CoimbraCentro Hospitalar e Universitário de CoimbraCentro Hospitalar e Universitário de CoimbraCentro Hospitalar e Universitário de CoimbraPrimary immunodeficiencies (PIDs) encompass more than 250 different pathological conditions. X-linked agammaglobulinemia (XLA) has been occasionally associated with cutaneous and muscular manifestations resembling dermatomyositis, often termed dermatomyositis-like syndrome (DLS). This syndrome has been associated with cutaneous, muscular and central nervous system manifestations, accompanying a persistent infection by an Echovirus. According to sixteen previously reported cases, this syndrome has a poor prognosis. We report the case of a 27-years old male, with XLA and DLS, successfully treated with 6 cycles of human immunoglobulin and methotrexate. Clinical symptoms improved dramatically with a complete resolution of the musculoskeletal manifestations. Despite this clinical response, prognosis should remain reserved. The evolution of this syndrome remains unpredictable and therapeutic options are limited. To the best of our knowledge, there are only a few reports of similar cases which have survived so many months after the diagnosis.http://www.actareumatologica.com/files/article/1091_dermatomyositis_like_syndrome_in_x_linked_agammaglobulinemia_file.pdfdermatomyositis-like syndromeX-linked agammaglobulinemiaImmunoglobulinprimary immunodeficiencies
collection DOAJ
language English
format Article
sources DOAJ
author Pedro David Carvalho
Carlos Costa
Marília Rodrigues
Maria João Salvador
José António Pereira da Silva
Armando Malcata
spellingShingle Pedro David Carvalho
Carlos Costa
Marília Rodrigues
Maria João Salvador
José António Pereira da Silva
Armando Malcata
Dermatomyositis-like syndrome in x-linked agammaglobulinemia
Acta Reumatológica Portuguesa
dermatomyositis-like syndrome
X-linked agammaglobulinemia
Immunoglobulin
primary immunodeficiencies
author_facet Pedro David Carvalho
Carlos Costa
Marília Rodrigues
Maria João Salvador
José António Pereira da Silva
Armando Malcata
author_sort Pedro David Carvalho
title Dermatomyositis-like syndrome in x-linked agammaglobulinemia
title_short Dermatomyositis-like syndrome in x-linked agammaglobulinemia
title_full Dermatomyositis-like syndrome in x-linked agammaglobulinemia
title_fullStr Dermatomyositis-like syndrome in x-linked agammaglobulinemia
title_full_unstemmed Dermatomyositis-like syndrome in x-linked agammaglobulinemia
title_sort dermatomyositis-like syndrome in x-linked agammaglobulinemia
publisher Sociedade Portuguesa de Reumatologia
series Acta Reumatológica Portuguesa
issn 0303-464X
publishDate 2016-01-01
description Primary immunodeficiencies (PIDs) encompass more than 250 different pathological conditions. X-linked agammaglobulinemia (XLA) has been occasionally associated with cutaneous and muscular manifestations resembling dermatomyositis, often termed dermatomyositis-like syndrome (DLS). This syndrome has been associated with cutaneous, muscular and central nervous system manifestations, accompanying a persistent infection by an Echovirus. According to sixteen previously reported cases, this syndrome has a poor prognosis. We report the case of a 27-years old male, with XLA and DLS, successfully treated with 6 cycles of human immunoglobulin and methotrexate. Clinical symptoms improved dramatically with a complete resolution of the musculoskeletal manifestations. Despite this clinical response, prognosis should remain reserved. The evolution of this syndrome remains unpredictable and therapeutic options are limited. To the best of our knowledge, there are only a few reports of similar cases which have survived so many months after the diagnosis.
topic dermatomyositis-like syndrome
X-linked agammaglobulinemia
Immunoglobulin
primary immunodeficiencies
url http://www.actareumatologica.com/files/article/1091_dermatomyositis_like_syndrome_in_x_linked_agammaglobulinemia_file.pdf
work_keys_str_mv AT pedrodavidcarvalho dermatomyositislikesyndromeinxlinkedagammaglobulinemia
AT carloscosta dermatomyositislikesyndromeinxlinkedagammaglobulinemia
AT mariliarodrigues dermatomyositislikesyndromeinxlinkedagammaglobulinemia
AT mariajoaosalvador dermatomyositislikesyndromeinxlinkedagammaglobulinemia
AT joseantoniopereiradasilva dermatomyositislikesyndromeinxlinkedagammaglobulinemia
AT armandomalcata dermatomyositislikesyndromeinxlinkedagammaglobulinemia
_version_ 1725721144307220480